TAGCyx Biotechnologies
Latest round
- Series A
Last raised
- Apr 2018
Total raised
- $4.6M
Investors
- 4
About TAGCyx Biotechnologies
TAGCyx Biotechnologies, Inc.Established in 2007 and headquartered in Tokyo, Japan, TAGCyx Biotechnologies focuses on high-performance nucleic acid therapies.TAGCyx Biotechnologies specializes in high-performance nucleic acid drugs, offering advanced aptamers and its proprietary Xenoligo® technology.TAGCyx Biotechnologies generates revenue through B2B partnerships and collaborations with academic institutions and pharmaceutical companies.
Who invested in TAGCyx Biotechnologies
4 investors across 1 round
See all investors in TAGCyx Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 24, 2018
Amount
$4.6M
Investors
Questions about TAGCyx Biotechnologies
Who invested in TAGCyx Biotechnologies?
TAGCyx Biotechnologies has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TAGCyx Biotechnologies raised?
TAGCyx Biotechnologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did TAGCyx Biotechnologies last raise money?
TAGCyx Biotechnologies's most recent round on record is a Series A, in Apr 2018.
What does TAGCyx Biotechnologies do?
TAGCyx Biotechnologies is a biotechnology company.
Where is TAGCyx Biotechnologies headquartered?
TAGCyx Biotechnologies is headquartered in Tokyo, Japan.
Which VCs invest in companies like TAGCyx Biotechnologies?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at TAGCyx Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like TAGCyx Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.